Halothane

Fluothane (halothane) is a small molecule pharmaceutical. Halothane was first approved as Fluothane on 1982-01-01. It is used to treat status asthmaticus in the USA. The pharmaceutical is active against potassium channel subfamily K member 10 and potassium channel subfamily K member 9. In addition, it is known to target potassium channel subfamily K member 12, potassium channel subfamily K member 2, potassium channel subfamily K member 3, potassium channel subfamily K member 5, potassium channel subfamily K member 13, potassium voltage-gated channel subfamily B member 1, and G protein-activated inward rectifier potassium channel 2.